| 61/68 | US=16 / Urologia Kortenhorst MSQ, Carducci MA, Shabbeer S. Therapeutics: differentiation agents and epigenomic therapies. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 411-43. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. CANCER DE PROSTATA; TERAPEUTICA; AGENTES DE DIFERENCIACAO; TERAPIA EPIGENOMICA; ACETILACAO; MODIFICACAO DA CROMATINA; REMODELAMENTO DA CROMATINA; ENSAIOS CLINICOS; EPIGENETICA; HISTONA ACETIL TRANSFERASE; CODIGO DE HISTONAS; INIBIDOR DE HISTONA-DESACETILASE; METILACAO; INIBIDOR METIL TRANSFERASE |
| 62/68 | US=16 / Urologia Mohile SG, Petrylak DP. Therapeutics: taxane-based chemotherapy for prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 445-62. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. CANCER DE PROSTATA; TERAPEUTICA; TAXANO; QUIMIOTERAPIA; DOCETAXEL; ESTRAMUSTINA; PACLITAXEL; PALIACAO; RESISTENCIA; SOBREVIVENCIA; TAXANO |
| 63/68 | US=16 / Urologia Assikis V. Therapeutics: co-targeting therapeutics for hormone refractory prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 463-73. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. CANCER DE PROSTATA; TERAPEUTICA; CO-SEGMENTACAO TERAPEUTICA; HORMONIO REFRATARIO; ANGIOGENESE; METASTASES OSSEAS; MICROAMBIENTE OSSEO; ESTROMA |
| 64/68 | US=16 / Urologia Whang YE, George DJ. Therapeutics: intercellular targets of protaste cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 475-86. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. CANCER DE PROSTATA; TERAPEUTICA; METAS INTERCELULARES; FATOR DE CRESCIMENTO EPIDERMICO; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR; FATOR DE CRESCIMENTO DERIVADO DE PLAQUETAS; ENDOTELINAS; INSULINA COMO FATOR DE CRESCIMENTO; FACTOR DE CRESCIMENTO DE FIBROBLASTOS |
| 65/68 | US=16 / Urologia Rogtko A, Tighiouart M. Therapeutics: novel and efficient translational clinical trial designs in advanced prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 487-95. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. CANCER DE PROSTATA; TERAPEUTICA; PROJETOS DE TRANSLACAO; ENSAIOS CLINICOS; CANCER DE PROSTATA AVANCADO; CONCEPCAO BAYESIANA; ESCALONAMENTO DE DOSE; ESCALADA COM OVERDOSE DE CONTROLE; EWOC; OVERDOSE DE CONTROLE; PROJETO FASE I |
| 66/68 | US=82 / Biol/Mol Schulz WA. Prostate cancer. In: ___. Molecular biology of human cancers: an advanced student's textbook. New York: Springer, 2007. p. 383-402. ISBN 978-1-4020-6559-0. CANCER DE PROSTATA; CANCER DE PROSTATA. EPIDEMIOLOGIA; ANDROGENOS; GENETICA; EPIGENETICA; INTERACAO TUMOR-ESTROMA |
| 67/68 | US=32 / Biol/Mol Knudsen S. Prostate cancer. In: ___. Cancer diagnostics with DNA microarrays. New Jersey: John Wiley & Sons, 2006. p. 134-7. ISBN 978-0-471-78407-4. |
| 68/68 | US=23 / Urologia Ulchaker JC, Ciezki JP. Prostate cancer. In: Novick AC, Jones JS, Gill IS, Klein EA, Rackley R, Ross JH. Operative urology: at the cleveland clinic. Totowa: Humana Press, 2006. p. 373-5. ISBN 1-58829-081-6. |